(Reuters) - Pfizer Inc said it could not decide whether to pursue regulatory approval for Pain Therapeutics Inc's painkiller Remoxy, for which the United States Food and Drug Administration sought additional studies.

Miami, FL 05/15/2013 (GDPInsider) - Pain Therapeutics, Inc (NASDAQ:PTIE): Tuesday's trading session saw Pain Therapeutics, Inc (NASDAQ:PTIE) shares headed 2.55% upward. The opening price of $2.78 touched an intraday high of $2.82 per share and ...

Among the companies with shares expected to actively trade in Friday's session are Gap Inc. (GPS) Pain Therapeutics Inc. (PTIE) and Air Lease Corp (AL). Gap issued fiscal first-quarter projections that beat consensus estimates, while reporting same ...

Pain Therapeutics, Inc. (NASDAQ:PTIE) is raised by 2.61% in Monday trading and closed at $2.75, after starting its day with a value of $2.71.

(Reuters) - Shares of Pain Therapeutics Inc (PTIE.O) and Durect Corp (DRRX.O) rose more than 40 percent after partner Pfizer Inc (PFE.

San Diego, CA -- (SBWIRE) -- 05/14/2013 -- An investigation on behalf of investors of Pain Therapeutics, Inc. (NASDAQ:PTIE) shares over potential securities laws violations by Pain Therapeutics and certain of its directors and officers in connection ...

Related Topics. Stocks � · Markets � · Healthcare �. NEW YORK | Fri May 10, 2013 8:16am EDT. NEW YORK May 10 (Reuters) - Pain Therapeutics Inc : * Shares down 43 percent, DURECT Corp down 36.5 percent in premarket. trading. Stocks · Markets ...

Pain Therapeutics Inc. (NASDAQ:PTIE) a biopharmaceutical company that develops novel drugs is currently up (+1.19%) on 893,973 shares traded after PAIN THERAPEUTICS INC Filed SEC form 8-K, Regulation FD Disclosure, Financial Statements and ...

Drug developer Pain Therapeutics Inc. (PTIE, $2.68, -$2.64, -49.62%) said Pfizer Inc. (PFE, $28.72, +$0.12, +0.42%) is evaluating its participation in the development of the pain-medicine candidate Remoxy.

Wilmington, DE -- (SBWIRE) -- 05/10/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding Pain Therapeutics Inc. (NASDAQ:PTIE), DURECT Corporation (NASDAQ:DRRX), and Medivation, Inc. (NASDAQ:MDVN).